Friday, 30 October 2009
COST: Newsletter available
The European Co-operation in the Field of Science and Technology (COST) has just published a Newsletter which highlights past and upcoming COST Activities, describes instruments and covers COST stories.
Tuesday, 27 October 2009
Ethics help desk available
The newly created Ethics Help Desk for FP7 projects now provides information on issues and offers consultation regarding the ethical aspects of research that is funded under the 7th Framework Programme. The goal of the Help-Desk is to support scientists that are research participants in FP7 funded projects, to meet the EU and international ethical standards related to the issues outlined in the "Ethics check list".
Via this service, scientists can receive advice from the Ethics Review Sector of DG research and by experts in the ethics field concerned, in order to reach their research objectives and meet the ethical requirements of their work.
The advice is offered on the basis of the FP7 ethics framework as outlined in the FP7 legal basis documents and the legal documents for implementation.
The Ethics Help Desk Contact person is Isidoros Karatzas.
All questions will be treated confidentially and personal information will be protected. More information as well as contact details you will find on the cordis "get support" page.
Via this service, scientists can receive advice from the Ethics Review Sector of DG research and by experts in the ethics field concerned, in order to reach their research objectives and meet the ethical requirements of their work.
The advice is offered on the basis of the FP7 ethics framework as outlined in the FP7 legal basis documents and the legal documents for implementation.
The Ethics Help Desk Contact person is Isidoros Karatzas.
All questions will be treated confidentially and personal information will be protected. More information as well as contact details you will find on the cordis "get support" page.
Tuesday, 13 October 2009
Friday, 9 October 2009
Second IMI call to be launched in October
The Innovative Medicines Initiative (IMI) is a Public-Private Partnership (PPP) between the pharmaceutical industry represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Communities represented by the European Commission.
On 30 October 2009 the 2nd call for proposals of IMI will be launched officially. Concerning the funding available for the new call, there will be 76.8 million provided by the European Commission with at least matching in kind contributions to the projects of the participating EFPIA companies. Nine topics will be covered, related to knowledge management, infectious and inflammatory diseases, and cancer.
The IMI Call is a two-stage process, the first one being an Expression of Interest (EoI) expressed by scientists from academia, SME, patient organisations and others. One EoI per Call topic is generally invited to submit a full project proposal together with the EFPIA industry members. The submission deadline for EoIs will probably be in january 2010.
An information day held on Tuesday, 17 Nov 09 at Brussels-Expo will provide an overview of the IMI and all practical information to be involved in IMI projects, focusing on the submission of expressions of interest for the 2nd call.
For more information please refer to the IMI web site.
A comparison between FP7 and IMI funding as well as information on the IMI IRP policy which clearly aims at a swift dissemination and sharing of the results can be found on the Euresearch web site.
On 30 October 2009 the 2nd call for proposals of IMI will be launched officially. Concerning the funding available for the new call, there will be 76.8 million provided by the European Commission with at least matching in kind contributions to the projects of the participating EFPIA companies. Nine topics will be covered, related to knowledge management, infectious and inflammatory diseases, and cancer.
The IMI Call is a two-stage process, the first one being an Expression of Interest (EoI) expressed by scientists from academia, SME, patient organisations and others. One EoI per Call topic is generally invited to submit a full project proposal together with the EFPIA industry members. The submission deadline for EoIs will probably be in january 2010.
An information day held on Tuesday, 17 Nov 09 at Brussels-Expo will provide an overview of the IMI and all practical information to be involved in IMI projects, focusing on the submission of expressions of interest for the 2nd call.
For more information please refer to the IMI web site.
A comparison between FP7 and IMI funding as well as information on the IMI IRP policy which clearly aims at a swift dissemination and sharing of the results can be found on the Euresearch web site.
Tuesday, 22 September 2009
Guidance Notes for Beneficiaries and Auditors: Update available
On 3 September 2009, the European Commission issued a revised version of the Guidance Notes for Beneficiaries and Auditors on FP7 audit certification issues.
The objective of these guidance notes is to give an overview of the requirements and provisions which are of importance in claiming costs for reimbursement and hence in the Certification on the Financial Statements and on the Methodology. The document is composed of Part I dealing with the Certificates on the Methodology, Part II covering the Certificates on the Financial Statements and Part III which is a common glossary for both types of Certificates.
This is the second update of the document. The following modifications, product of experience, new developments and feedback from users, have been introduced:
– the adoption by the Commission on 23 June 2009 of the acceptability criteria for the assessment of average personnel costs methodologies (Part I - 5.4 and Annex II)
– the particular case of average personnel costing methodologies for physical persons and SME owners who do not receive a salary (Part I – 5.3.4)
– additional information/explanations and/or rewording further to questions raised through the Research Enquiry Service.
Download here.
The objective of these guidance notes is to give an overview of the requirements and provisions which are of importance in claiming costs for reimbursement and hence in the Certification on the Financial Statements and on the Methodology. The document is composed of Part I dealing with the Certificates on the Methodology, Part II covering the Certificates on the Financial Statements and Part III which is a common glossary for both types of Certificates.
This is the second update of the document. The following modifications, product of experience, new developments and feedback from users, have been introduced:
– the adoption by the Commission on 23 June 2009 of the acceptability criteria for the assessment of average personnel costs methodologies (Part I - 5.4 and Annex II)
– the particular case of average personnel costing methodologies for physical persons and SME owners who do not receive a salary (Part I – 5.3.4)
– additional information/explanations and/or rewording further to questions raised through the Research Enquiry Service.
Download here.
Tuesday, 8 September 2009
New info sheet available: FP7 3rd Country Involvement
Experience with the first calls in FP7 shows that the administrative and legal aspects related to the participation of organisations from so-called Third Countries are often a particular challenge for consortia. Not least, this can lead to significant delays in grant negotiations.
The Commission has therefore prepared a quick guide that focuses on the cooperation with third country participants in the 7th Framework Programme. The guide was prepared to assist future consortia in submitting proposals and to speed up the negotiation process. It can be downloaded from the Euresearch site.
The Commission has therefore prepared a quick guide that focuses on the cooperation with third country participants in the 7th Framework Programme. The guide was prepared to assist future consortia in submitting proposals and to speed up the negotiation process. It can be downloaded from the Euresearch site.
Wednesday, 2 September 2009
Funds to develop alternative solutions to animal testing
The European Commission and the cosmetic industry match research funds to develop alternative solutions to animal testing.
On 30 July 2009, the European Commission launched a €25 million call for proposals in this field and the European cosmetic industry, represented by the European Cosmetics Association (Colipa), committed to match the funds. As a result, up to €50 million will be allocated to research projects laying the scientific foundation for future safety testing methods with a higher predictive value, and that will be faster and cheaper than animal tests.
With this call, the European Commission is seeking proposals for research projects involving a wide range of scientific partners across Europe and focusing on the following topics:
- development of organ-simulating devices;
- use of human-based target cells;
- definition of new toxicological endpoints and intermediate markers
- computational modelling techniques
- exploitation of approaches developed in systems biology; and
- integrated data analysis and scientific services.
Through the co-operation between the European Commission and Colipa, the projects selected can be funded up to 100% of their total eligible costs.
More information can be found in the related Europa press release of 31 Aug 09.
On 30 July 2009, the European Commission launched a €25 million call for proposals in this field and the European cosmetic industry, represented by the European Cosmetics Association (Colipa), committed to match the funds. As a result, up to €50 million will be allocated to research projects laying the scientific foundation for future safety testing methods with a higher predictive value, and that will be faster and cheaper than animal tests.
With this call, the European Commission is seeking proposals for research projects involving a wide range of scientific partners across Europe and focusing on the following topics:
- development of organ-simulating devices;
- use of human-based target cells;
- definition of new toxicological endpoints and intermediate markers
- computational modelling techniques
- exploitation of approaches developed in systems biology; and
- integrated data analysis and scientific services.
Through the co-operation between the European Commission and Colipa, the projects selected can be funded up to 100% of their total eligible costs.
More information can be found in the related Europa press release of 31 Aug 09.
Subscribe to:
Posts (Atom)